(VIANEWS) – BOLLORE (BOL.PA), IBA (IBAB.BR), MEDISTIM (MEDI.OL) are the highest payout ratio stocks on this list.
We have gathered information regarding stocks with the highest payout ratio at the moment. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. BOLLORE (BOL.PA)
100% Payout Ratio
Bolloré SE engages in the transportation and logistics, communications, and industry businesses in France, rest of Europe, the Americas, Asia, Oceania, and Africa. It operates through Bolloré Logistics, Bolloré Energy, Communications, and Industry segments. The company offers freight forwarding, railroad, and port services; and distributes oil products. It also provides advertising, and communication consulting services; owns and publishes Cnews, a French daily newspaper; provides ticketing and venue services; acts as a pay-TV operator; and operates Mac-Mahon cinema theaters. In addition, it develops batteries based on lithium metal polymer technology for use in electric buses and energy storage solutions, as well as in stationary applications; and polypropylene films for capacitors and electrical components. Further, the company integrates identification, tracking, and mobility solutions for retail, transport, and logistics; provides equipment for pedestrian and vehicle access control; and electric shuttles solutions. The company was founded in 1822 and is based in Puteaux, France. Bolloré SE is a subsidiary of Financière de l'Odet SE.
Earnings Per Share
As for profitability, BOLLORE has a trailing twelve months EPS of €0.06.
PE Ratio
BOLLORE has a trailing twelve months price to earnings ratio of 98.92. Meaning, the purchaser of the share is investing €98.92 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.04%.
Volume
Today’s last reported volume for BOLLORE is 225134 which is 83.18% below its average volume of 1338540.
Moving Average
BOLLORE’s worth is higher than its 50-day moving average of €5.81 and above its 200-day moving average of €5.40.
Yearly Top and Bottom Value
BOLLORE’s stock is valued at €5.93 at 17:10 EST, under its 52-week high of €6.37 and way higher than its 52-week low of €4.48.
More news about BOLLORE.
2. IBA (IBAB.BR)
94.67% Payout Ratio
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Earnings Per Share
As for profitability, IBA has a trailing twelve months EPS of €0.2.
PE Ratio
IBA has a trailing twelve months price to earnings ratio of 75. Meaning, the purchaser of the share is investing €75 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.01%.
Volume
Today’s last reported volume for IBA is 1472 which is 87.56% below its average volume of 11838.
More news about IBA.
3. MEDISTIM (MEDI.OL)
59.15% Payout Ratio
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.34.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 41.01. Meaning, the purchaser of the share is investing kr41.01 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.89%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 25, 2023, the estimated forward annual dividend rate is 4.5 and the estimated forward annual dividend yield is 1.6%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MEDISTIM’s EBITDA is 114.4.
More news about MEDISTIM.
4. WDP (WDP.BR)
47.31% Payout Ratio
WDP develops and invests in logistics real estate (warehouses and offices). WDP has 7 million m² of properties in its portfolio. This international portfolio of semi-industrial and logistics buildings is spread over about 300 sites at prime logistics hubs for storage and distribution in Belgium, France, the Netherlands, Luxembourg, Germany and Romania.
Earnings Per Share
As for profitability, WDP has a trailing twelve months EPS of €1.86.
PE Ratio
WDP has a trailing twelve months price to earnings ratio of 14.7. Meaning, the purchaser of the share is investing €14.7 for every euro of annual earnings.
More news about WDP.
5. GRAM CAR CARRIERS (GCC.OL)
35.31% Payout Ratio
Gram Car Carriers ASA, through its subsidiaries, operates as a tonnage supplier worldwide. The company invests in and operates assets in the pure car and truck carrier shipping segment. It also offers commercial management services for the 19 owned carriers and 1 vessel managed by third party. The company was founded in 2006 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, GRAM CAR CARRIERS has a trailing twelve months EPS of kr12.74.
PE Ratio
GRAM CAR CARRIERS has a trailing twelve months price to earnings ratio of 13. Meaning, the purchaser of the share is investing kr13 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.85%.
Sales Growth
GRAM CAR CARRIERS’s sales growth is negative 82.7% for the present quarter and negative 83.6% for the next.
More news about GRAM CAR CARRIERS.
6. TOTALENERGIES (TTE.PA)
34.84% Payout Ratio
TotalEnergies SE, a multi-energy company, produces and markets fuels, natural gas, and electricity in France, rest of Europe, North America, Africa, and internationally. It operates through Integrated Gas, Renewables & Power; Exploration & Production; Refining & Chemicals; and Marketing & Services segments. The Integrated Gas, Renewables & Power segment engages in integrated gas, including liquified natural gas (LNG), and low carbon electricity businesses; and upstream and midstream LNG activities. Its Exploration & Production segment offers carbon storage and nature-based solutions. The Refining & Chemicals segment provides refining, petrochemicals, and specialty chemicals; and supply and trading of oil, and marine shipping services. Its Marketing & Services segment engages in the supply and marketing of petroleum products. TotalEnergies SE was formerly known as TOTAL SE and changed its name to TotalEnergies SE in June 2021. The company was founded in 1924 and is headquartered in Courbevoie, France.
Earnings Per Share
As for profitability, TOTALENERGIES has a trailing twelve months EPS of €7.46.
PE Ratio
TOTALENERGIES has a trailing twelve months price to earnings ratio of 6.98. Meaning, the purchaser of the share is investing €6.98 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.15%.
Yearly Top and Bottom Value
TOTALENERGIES’s stock is valued at €52.07 at 17:10 EST, way below its 52-week high of €60.93 and way above its 52-week low of €45.81.
Revenue Growth
Year-on-year quarterly revenue growth declined by 8.9%, now sitting on 257.59B for the twelve trailing months.
More news about TOTALENERGIES.
